The plant-derived 'retinol alternative' — one genuinely promising head-to-head trial, and that's about it so far.
Bakuchiol is structurally unrelated to retinoids but appears to switch on an overlapping set of skin genes, nudging collagen production without engaging the irritation-prone retinoid receptors — the proposed reason it's better tolerated.
The key trial used 0.5% twice daily.
Matched retinol in one 44-person trial — promising, unreplicated
A 12-week randomized, double-blind trial (n=44) found 0.5% bakuchiol comparable to 0.5% retinol for wrinkles and pigmentation, with less stinging and dryness. Genuinely encouraging — but one small study is a data point, not a proof. Ideal if you can't tolerate retinoids.
Anchored to regulatory assessments — not hazard lists. Dose makes the poison; these are the conclusions at real-world cosmetic use.
Well tolerated in available studies and often suggested where retinoids aren't an option. Long-term safety data is limited simply because the ingredient is young; pregnancy safety is unstudied.